

Syncona Investee Freeline Modifies Hemophilia Plan After FDA Feedback


Syncona Investee Achilles Reports Positive Trial Review, Mulling IPO


(Sharecast News) - Healthcare investor Syncona said on Friday that its portfolio company Achilles Therapeutics, which is developing precision T-cell t...


Syncona Investee Autolus To Focus On Adult Leukemia Programme in 2021


(Sharecast News) - Life science investor Syncona updated the market on its portfolio company Autolus on Wednesday, announcing that it would prioritise...


UK EXECUTIVE CHANGE SUMMARY: Ferguson Taps Former Ashtead, Bunzl Execs


Syncona Portfolio Companies Boost Interim Result; Launches New Company


(Sharecast News) - Healthcare company Syncona reported a "robust" performance for the six months up to 30 September in which its net assets reached a ...